It looks like nothing was found at this location. Maybe try one of the links below or a search?
Recent Posts
- Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts
- Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study
- Prevention of post-contrast kidney injury in patients with cancer
- Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
- Autoimmune findings in patients with silicosis in Spain
Most Used Categories
- Haematology and Oncology (86)
- Dermatology (70)
- Infectious disease (69)
- Primary Care (69)
- Cardiology and cardiovascular disease (58)
- Health Economics & Outcomes Research (43)
- Endocrinology (42)
- Immunology (42)
- Paediatrics (42)
- Respiratory (39)
Archives
Try looking in the monthly archives. 🙂
Tags
antimicrobial stewardship
atopic dermatitis
Atrial fibrillation
breast cancer
cancer
cardiovascular disease
cardiovascular risk
case report
children
chronic kidney disease
Chronic obstructive pulmonary disease
connective tissue diseases
COPD
coronavirus
COVID-19
dapagliflozin
Dermatology
diabetes
Diabetes mellitus
efficacy
empagliflozin
heart failure
HIV
immunotherapy
inflammation
insulin
non-small-cell lung cancer
Oncology
ospemifene
paediatrics
Primary Care
psoriasis
quality of life
rheumatoid arthritis
safety
SARS-CoV-2
schizophrenia
silymarin
Stroke
targeted therapy
treatment
Type 2 diabetes
type 2 diabetes mellitus
vaccination
vulvar and vaginal atrophy